News

An antiviral surface coating technology sprayed on face masks could provide an extra layer of protection against COVID-19 and the flu.

AIBN Professor Trent Munro is leading a team to develop, test and manufacture specific therapeutics in Australia, including for use against COVID-19.

Researchers studying ageing in tiny ‘live’ models of the human brain have found a key to potential treatments for Alzheimer’s and other neurodegenerative diseases.

Improving a “trial-and-error approach’’ to epilepsy treatment is the aim of research that encompasses stem cells, artificial intelligence, brain organoids and drug screening.

Researchers could herald the the next generation of electronics with silicon-based technology.

High school students have received hands-on experience developing nanomedicines using state of the art technology.

Needle-free technology, originally developed at the AIBN, has been used to administer a COVID-19 vaccine candidate to successfully protect mice, demonstrating the potential of non-invasive delivery.

A pilot facility at AIBN could be producing mRNA vaccines and cancer therapies for research and development within months after receiving backing from the Australian Government.

Faster-charging and more sustainable batteries with a life up to three times greater than lithium ion are being built with technology developed at AIBN.

University of Queensland scientists have published the clinical trial data confirming their molecular clamp-stabilised vaccine technology was safe and potentially effective.

On International Womens’ Day, we asked AIBN’s Dr Nasim Amiralian what advice she would give to her 16-year-old self, if she could mentor a younger Nasim.

Greenhouse gas waste from factories could be turned into environmentally-friendly chemicals and fuels under an international project seeking to better understand the gene function of bacteria.

AIBN researchers have developed a diagnostic device, called an Immuno-storm chip, that could identify which cancer and COVID-19 patients are at risk of a potentially lethal ‘cytokine storm’.

Astronauts aboard the International Space Station (ISS) are conducting experiments with an antimicrobial surface developed at AIBN.

AIBN’s Professor Yusuke Yamauchi has been named as a Research Project Director by the Exploratory Research for Advanced Technology (ERATO) funding program, an initiative of the Japan Science and Technology Agency.

Professor Lianzhou Wang and Professor Yusuke Yamauchi have been named among the world’s most influential minds for 2020’s Highly Cited Research list.

A materials scientist from AIBN has been recognised by a prestigious national body for using his scientific and engineering expertise to help solve global challenges.

A colourful landscape with a large rock in the centre or intestinal microfold monolayer cells?
The 2020 AIBN Science Image Contest has highlighted the role imagination and creativity play in scientific research.

Sugarcane waste could be a key ingredient in tackling plastic pollution, with an AIBN researcher receiving funding to turn the green waste into sustainable packaging.

AIBN researcher Associate Professor Jessica Mar has received a 2020 Georgina Sweet Award for Women in Quantitative Biomedical Science. The award was given to Assoc Professor Mar for both Excellence in Research and Excellence in Inclusivity.